ChartRow logo
ChartRow
Stocks and ETFs
VRTX
Vertex Pharmaceuticals IncorporatedStock · Healthcare
$528.04+$30.03 (+6.03%)as of market close, Jul 2, 2026
CompareLLYUNHJNJABBVMRKABT

VRTX monthly returns

Vertex Pharmaceuticals Incorporated has averaged 2.07% per month, positive in 55% of months. Month-by-month returns for Vertex Pharmaceuticals Incorporated (VRTX) below, through July 2, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.

Average month
+2.1%
415 months
Best month
+77.1%
Feb 2000
Worst month
-51.1%
Sep 2001
Positive months
55%
of all months

Vertex Pharmaceuticals Incorporated monthly returns#

Vertex Pharmaceuticals Incorporated total return by month
MonthTotal return
Jul 2026
+6.3%
Jun 2026
+11.0%
May 2026
+4.7%
Apr 2026
-4.3%
Mar 2026
-10.1%
Feb 2026
+5.7%
Jan 2026
+3.6%
Dec 2025
+4.6%
Nov 2025
+1.9%
Oct 2025
+8.7%
Sep 2025
+0.2%
Aug 2025
-14.4%

Monthly total return (since Aug 2021)

-15%-10%-5%+0%+5%+10%+15%
20222023202420252026

Methodology#

Monthly returns are total returns (dividends reinvested), computed from VRTX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.

See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum

FAQ

What is Vertex Pharmaceuticals Incorporated's average monthly return?
Vertex Pharmaceuticals Incorporated (VRTX) has averaged about 2.07% per month, positive in roughly 55% of months. The best month was Feb 2000 (+77.1%) and the worst was Sep 2001 (-51.1%).